HB 1419

  • Tennessee House Bill
  • 113th Regular Session (2023-2024)
  • Introduced in House Feb 02, 2023
  • House
  • Passed Senate Feb 06, 2023
  • Governor

Drugs, Prescription - As introduced, prohibits a healthcare prescriber from issuing a prescription for a dual-purpose prescription medication for diabetes to a person in this state if the person does not have a diagnosis of diabetes; defines a dual-purpose prescription medication for diabetes as a prescription drug that has a listed indication for diabetes and may also be used for purposes of weight loss in persons who do not have a diagnosis of diabetes. - Amends TCA Title 53; Title 56; Title 63; Title 68 and Title 71.


No votes to display


Feb 07, 2023


Assigned to s/c Health Subcommittee

Feb 06, 2023


Passed on Second Consideration, refer to Senate Commerce and Labor Committee

Feb 02, 2023


P2C, ref. to Health Committee


Introduced, Passed on First Consideration

Feb 01, 2023


Intro., P1C.

Jan 31, 2023


Filed for introduction


Filed for introduction

Bill Text

Bill Text Versions Format
Current Version PDF

Related Documents

Document Format
Fiscal Note


Data on Open States is updated periodically throughout the day from the official website of the Tennessee General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.